SSG
ENFN

Summit Securities Group’s Enfusion, Inc. ENFN Stock Holding History

Summit Securities Group’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,165
Closed -$30K – 950
2024
Q3 		$30K Buy
3,165
+2,165
+217% +$18.7K 0.01% 297
2024
Q2 		$9K Hold
1,000
– – ﹤0.01% 450
2024
Q1 		$9K Sell
1,000
-500
-33% -$4.4K ﹤0.01% 348
2023
Q4 		$15K Hold
1,500
– – ﹤0.01% 493
2023
Q3 		$13K Hold
1,500
– – ﹤0.01% 404
2023
Q2 		$17K Buy
+1,500
New +$13.3K ﹤0.01% 682

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Summit Securities Group's ENFN Position: Q4 2024 in Review

Summit Securities Group sold out of Enfusion, Inc. (ENFN) in Q4 2024, closing a stake of 3,165 shares — an estimated $30K sold.

Summit Securities Group first reported a position in ENFN in Q2 2023 and held it in 6 quarters. The position peaked at $30K in Q3 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q4 2024.

  • Summit Securities Group reported no remaining Enfusion, Inc. position as of Q4 2024 after selling out during the quarter.
  • Summit Securities Group sold 3,165 Enfusion, Inc. shares in Q4 2024, an estimated $30K.
  • Summit Securities Group first reported a position in Enfusion, Inc. in Q2 2023 and held it in 6 quarters.
  • Summit Securities Group's Enfusion, Inc. position peaked at $30K in Q3 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q4 2024.

Based on Summit Securities Group's 13F filing for Q4 2024, filed 12 Feb 2025.